3rd Quarter - Termination
OGR for BRISTOL-MYERS SQUIBB
Firm
Client
Income
$30,000
Expenses
—
Terminated
Sep 30, 2012
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
S.3187/H.R.5651, Food and Drug Administration Safety and Innovation Act (Public Law No: 112-144); Medical Device User Fee Act and related issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| J MICHAEL HOGAN | — |
| GORDON TAYLOR | — |
| STEVE TILTON | — |
Health Issues HCR
Issues related to the implementation of the Patient Protection and Affordable Care Act, Prescription Drug User Fee Act reauthorization, health care and mental health.
| Lobbyist | Covered position, as disclosed |
|---|---|
| J MICHAEL HOGAN | — |
| GORDON TAYLOR | — |
| STEVE TILTON | — |
Medicare/Medicaid MMM
Issues related to Medicare and Medicaid.
| Lobbyist | Covered position, as disclosed |
|---|---|
| J MICHAEL HOGAN | — |
| GORDON TAYLOR | — |
| STEVE TILTON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.